G. Martin, Nainita Roy, Sohini Chakraborty, A. Desrichard, S. Chung, Carolien M Woolthuis, Wenhuo Hu, Iryna Berezniuk, Francine E. Garrett-Bakelman, J. Hamann, S. Devlin, T. Chan, Christopher Y. Park
{"title":"CD97是急性髓系白血病干细胞功能的关键调节因子","authors":"G. Martin, Nainita Roy, Sohini Chakraborty, A. Desrichard, S. Chung, Carolien M Woolthuis, Wenhuo Hu, Iryna Berezniuk, Francine E. Garrett-Bakelman, J. Hamann, S. Devlin, T. Chan, Christopher Y. Park","doi":"10.1084/jem.20190598","DOIUrl":null,"url":null,"abstract":"Martin et al. demonstrate that CD97 is a critical regulator of leukemia stem cell (LSC) function. CD97 is overexpressed in the vast majority of AML patients and promotes AML blast growth, survival, and differentiation. Collectively, these data credential CD97 as a novel and promising therapeutic target in AML.","PeriodicalId":23015,"journal":{"name":"The Tokushima journal of experimental medicine","volume":"19 1","pages":"2362 - 2377"},"PeriodicalIF":0.0000,"publicationDate":"2019-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"27","resultStr":"{\"title\":\"CD97 is a critical regulator of acute myeloid leukemia stem cell function\",\"authors\":\"G. Martin, Nainita Roy, Sohini Chakraborty, A. Desrichard, S. Chung, Carolien M Woolthuis, Wenhuo Hu, Iryna Berezniuk, Francine E. Garrett-Bakelman, J. Hamann, S. Devlin, T. Chan, Christopher Y. Park\",\"doi\":\"10.1084/jem.20190598\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Martin et al. demonstrate that CD97 is a critical regulator of leukemia stem cell (LSC) function. CD97 is overexpressed in the vast majority of AML patients and promotes AML blast growth, survival, and differentiation. Collectively, these data credential CD97 as a novel and promising therapeutic target in AML.\",\"PeriodicalId\":23015,\"journal\":{\"name\":\"The Tokushima journal of experimental medicine\",\"volume\":\"19 1\",\"pages\":\"2362 - 2377\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"27\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Tokushima journal of experimental medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1084/jem.20190598\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Tokushima journal of experimental medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1084/jem.20190598","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
CD97 is a critical regulator of acute myeloid leukemia stem cell function
Martin et al. demonstrate that CD97 is a critical regulator of leukemia stem cell (LSC) function. CD97 is overexpressed in the vast majority of AML patients and promotes AML blast growth, survival, and differentiation. Collectively, these data credential CD97 as a novel and promising therapeutic target in AML.